Tumor & Cancer Immunology-2016: Past Conference Report

Conference series LLC hosted the “International Conference on Tumor & Cancer Immunology and Immunotherapy” during July 28-30, 2016 at Holiday Inn Melbourne Airport 10-14 Centre Road, Melbourne Airport, Australia with the theme “Latest Advances in Tumor & Cancer Immunotherapy from Vaccines to Antibodies and Cell Therapies” was a great success, where eminent keynote speakers from various reputed institutions and organizations with their resplendent presence addressed the gathering.

Benevolent response and active participation was received from the renowned experts and Editorial Board Members of Conference series Journals as well as from the Immunologists, Scientists, Researchers, Students and Leaders in Cancer research, Tumor related research field, Immunology, who made this event successful.

The Conference was carried out through various informative and cutting edge sessions, in which the discussions were held on the following thought provoking and cerebrating scientific tracks:

·         Tumors

·         Brain Tumors

·         Immune System-Tumors

·         Immunotherapy-Tumors

·         Tumor Immunology

·         Tumor Cells

·         Cancer Vaccines

·         Cancer Immunology & Immunotherapy

·         Immune Checkpoint Inhibitors

·         Cancer Research

·         Combining Cancer Immunotherapies

·         Tumor Immunotherapy Research

·         Cancer Micro and Immuno Environment

·         Tumor Markers and Drug Targeting

·         Tumorigenesis

·         Cancer Clinical Trials

·         Tumor Biology

·         Cancer Biomarkers

·         Immuno-Oncology Studies

·         Immunotherapy Monitoring

·         Antibodies Treatment: Cancer

·         Engineered T-Cell Therapy

·         Novel Approaches

The conference was embarked with an opening ceremony followed by a series of lectures delivered by Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

·         KN Leung, The Chinese University of Hong Kong, China

·         Jennifer Wu, Hollings Cancer Centre, USA

·         Liang Xu, University of Kansas Cancer Centre, USA

·         Kenichiro Hasumi, Hasumi International Research Foundation, Japan

All the above mentioned Honorable Guests and Keynote speakers gave their energetic and fruitful contributions and special thanks to our Honorable Moderator Takehiko Okamura, for his remarkable contribution towards smooth functioning at Tumor & Cancer Immunology-2016 Conference.

Conference Sessions Chairs:

·         Liang Xu, University of Kansas Cancer Centre, USA

·         Dean Mann, Hasumi International Research Foundation, Japan

·         KN Leung, The Chinese University of Hong Kong, China

Best Young Researcher Awards:

·         Title: Beyond CTLA-4 and PD-1: Orphan nuclear receptor NR2F6 as T cell signaling switch and emerging target in cancer immunotherapy.

Victoria Klepsch, Medical University Innsbruck, Austria

·         Title: Bispecific antibodies in breast cancer immunotherapy, the path forward?

Joanie Del Bano, Aix-Marseille University, France

Conference Series LLC offers its heartfelt appreciation to Societies and Organizations includes Biotechin Asia, Technology Networks, Allied Academies, Andrew John Publishing Inc., New York Private Equity Forums and is also obliged to the Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who interlaced with Conference series LLC in supporting and making the conference as never before one.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Tumor & Cancer Immunology-2016, Conference Series LLC is delighted to announce the next event. Mark your calendars for the upcoming extravaganza, “2^nd International Conference on Tumor & Cancer Immunology & Immunotherapy” to be held during July 24-26, 2017 at Chicago, USA.

Let us meet again @ Tumor & Cancer Immunology-2017